What is the recommended treatment for a 20‑year‑old with a pruritic, erythematous pustular rash on the chest that has not improved with topical triamcinolone?

Clinical Approach to Pruritic Pustular Chest Rash Unresponsive to Triamcinolone

This 20-year-old requires oral doxycycline 100 mg twice daily for at least 6 weeks combined with continuation or escalation of topical corticosteroid therapy, with reassessment in 2 weeks to determine if bacterial culture and extended antibiotic therapy are needed.

Diagnostic Considerations

The presentation of raised erythematous pustules with pruritus on the chest that failed to respond to triamcinolone cream suggests several possibilities:

• Bacterial folliculitis or secondary infection (most likely given pustular nature and steroid failure)
• Acneiform eruption (common in this age group)
• Eosinophilic folliculitis (less common but possible)
• Acute generalized exanthematous pustulosis (AGEP) (if recent medication exposure)

The failure to respond to topical corticosteroid monotherapy is a critical clue—pustular lesions often represent either infectious processes or inflammatory conditions requiring antimicrobial therapy rather than steroids alone 1.

Treatment Algorithm

First-Line Management (Current Step)

Initiate oral tetracycline antibiotic therapy immediately:

• Doxycycline 100 mg twice daily OR
• Minocycline 50 mg twice daily OR
• Oxytetracycline 500 mg twice daily

Duration: Minimum 6 weeks 1

Continue topical therapy:

• Escalate to moderate-potency topical corticosteroid (the triamcinolone 0.1% already used is appropriate 2)
• Apply twice daily to affected areas 1

Rationale: Tetracyclines provide both antimicrobial coverage for gram-positive organisms and anti-inflammatory properties that target the inflammatory cascade in pustular eruptions 1. This dual mechanism addresses both potential bacterial superinfection and underlying inflammation.

Two-Week Reassessment Point

If no improvement or worsening after 2 weeks:

1. Obtain bacterial culture from pustule contents 1

2. Look for infection indicators:

   • Painful lesions (not just pruritic)
   • Yellow crusts or discharge
   • Pustules spreading to arms, legs, or trunk
   • Failure to respond to gram-positive coverage 1

3. If infection confirmed: Switch to culture-directed antibiotics for minimum 14 days 1

4. If no infection but persistent symptoms: Consider:

   • Short course systemic corticosteroids (prednisone 0.5-1 mg/kg for 7 days with taper over 4-6 weeks) 1
   • Dermatology referral for consideration of oral retinoids (isotretinoin 20-30 mg/day) 1 or alternative diagnoses

Critical Pitfalls to Avoid

Do not continue topical corticosteroid monotherapy. Triamcinolone alone is insufficient for pustular eruptions 2. While indicated for inflammatory dermatoses, pustules require antimicrobial coverage to prevent progression and address potential bacterial involvement.

Do not use topical antibiotics alone. Topical antibiotic monotherapy promotes resistance and is explicitly not recommended 3. Systemic therapy is required for this presentation.

Do not delay bacterial culture if no response occurs. When pustules persist despite appropriate oral antibiotics covering gram-positive organisms, bacterial culture becomes mandatory to identify resistant organisms or atypical pathogens 1.

Avoid hot water and skin irritants. Counsel the patient to avoid frequent hot water washing, OTC anti-acne products, and excessive sun exposure, while using alcohol-free moisturizers twice daily 1.

Alternative Diagnoses Requiring Different Management

If the patient has recent medication exposure (within 1-2 weeks), consider AGEP, which presents with sudden-onset pustules, fever, and neutrophilia 4, 5. This requires immediate drug discontinuation and supportive care rather than antibiotics.

If there is severe facial involvement with marked eosinophilia, eosinophilic folliculitis may require indomethacin or JAK inhibitors rather than tetracyclines 6, 7.

Evidence Strength

The recommendation for oral tetracyclines plus topical corticosteroids for pustular eruptions comes from Level II evidence with Grade B recommendations in the 2021 ESMO guidelines 1. While these guidelines address drug-induced rashes, the pathophysiology and treatment principles apply to pustular eruptions in general, as the inflammatory cascade and bacterial superinfection risk are similar mechanisms.

The 6-week duration is evidence-based for achieving sustained improvement and preventing relapse 1.